Patents by Inventor Yutaka Atsuta

Yutaka Atsuta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treating agent for irritable bowel syndrome
    Patent number: 7683090
    Abstract: Pharmaceutical compositions for treatment of irritable bowel syndrome including non-constipated irritable bowel syndrome such as diarrhea-predominant irritable bowel syndrome and alternating constipation/diarrhea irritable bowel syndrome in male and female patients, which may comprise administering a patient with from 0.001 to 0.05 mg of ramosetron hydrochloride as a daily dose or an equivalent molar amount of ramosetron or its pharmaceutically acceptable other salt.
    Type: Grant
    Filed: October 18, 2006
    Date of Patent: March 23, 2010
    Assignee: Astellas Pharma Inc.
    Inventors: Akito Nishida, Akira Niwa, Yutaka Atsuta
  • Treating agent for irritable bowel syndrome
    Patent number: 7358270
    Abstract: A therapeutic method and pharmaceutical compositions for treatment of irritable bowel syndrome including non-constipated irritable bowel syndrome such as diarrhea-predominant irritable bowel syndrome and alternating constipation/diarrhea irritable bowel syndrome in male and female patients, which may comprise administering a patient with from 0.001 to 0.05 mg of ramosetron hydrochloride as a daily dose or an equivalent molar amount of ramosetron or its pharmaceutically acceptable other salt.
    Type: Grant
    Filed: January 28, 2005
    Date of Patent: April 15, 2008
    Assignee: Astellas Pharma Inc.
    Inventors: Akito Nishida, Akira Niwa, Yutaka Atsuta
  • Treating agent for irritable bowel syndrome
    Publication number: 20070037866
    Abstract: A therapeutic method and pharmaceutical compositions for treatment of irritable bowel syndrome including non-constipated irritable bowel syndrome such as diarrhea-predominant irritable bowel syndrome and alternating constipation/diarrhea irritable bowel syndrome in male and female patients, which may comprise administering a patient with from 0.001 to 0.05 mg of ramosetron hydrochloride as a daily dose or an equivalent molar amount of ramosetron or its pharmaceutically acceptable other salt.
    Type: Application
    Filed: October 18, 2006
    Publication date: February 15, 2007
    Applicant: Astellas Pharma Inc.
    Inventors: Akito Nishida, Akira Niwa, Yutaka Atsuta
  • Treating agent for irritable bowel syndrome
    Publication number: 20050192329
    Abstract: A therapeutic method and pharmaceutical compositions for treatment of irritable bowel syndrome including non-constipated irritable bowel syndrome such as diarrhea-predominant irritable bowel syndrome and alternating constipation/diarrhea irritable bowel syndrome in male and female patients, which may comprise administering a patient with from 0.001 to 0.05 mg of ramosetron hydrochloride as a daily dose or an equivalent molar amount of ramosetron or its pharmaceutically acceptable other salt.
    Type: Application
    Filed: January 28, 2005
    Publication date: September 1, 2005
    Applicant: Yamanouchi Pharmaceutical Co., Ltd.
    Inventors: Akito Nishida, Akira Niwa, Yutaka Atsuta